Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 1,339 | 0 | 1,808 | 2,421 |
| Operating Income | -1,339 | N/A | -1,808 | -2,421 |
| Interest Expense | 2 | 0 | 2 | 2 |
| Pre-tax Income | -1,341 | 0 | -1,811 | -2,423 |
| Net Income Continuous | -1,341 | N/A | -1,811 | -2,423 |
| Net Income | $-1,341 | $N/A | $-1,811 | $-2,423 |
| EPS Basic Total Ops | -0.10 | N/A | -0.14 | -0.19 |
| EPS Basic Continuous Ops | -0.08 | N/A | -0.14 | -0.19 |
| EPS Diluted Total Ops | -0.10 | N/A | -0.14 | -0.19 |
| EPS Diluted Continuous Ops | -0.08 | N/A | -0.14 | -0.19 |
| EBITDA(a) | $-1,339 | $N/A | $-1,808 | $-2,421 |